-
1
Rosacea is a chronic inflammatory skin condition characterized by facial erythema, flushing, and papular lesions, affecting quality of life.
-
2
The pathogenesis of rosacea involves genetic predisposition, immune dysfunction, skin barrier impairment, and microbial dysbiosis.
-
3
Individuals with rosacea often exhibit metabolic comorbidities, including dyslipidemia, diabetes, and obesity, indicating systemic metabolic dysregulation.
-
4
Changes in the composition of facial sebum lipids, particularly elevated myristic acid, may contribute to skin barrier dysfunction in rosacea.
-
5
Ceramide-containing moisturizers may help restore skin barrier function and benefit individuals with rosacea by addressing lipid metabolism issues.